[Clinical study of a new oral hypoglycemic agent: glypentide (UR-661)].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D001549:Benzamides / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003517:Cyclopentanes / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D007223:Infant; D008297:Male; D008875:Middle Aged; D013453:Sulfonylurea Compounds / Q000008:administration & dosage* / Q000627:therapeutic use; D013607:Tablets
D001549:Benzamides; D003517:Cyclopentanes; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D013607:Tablets
Estudio clínico con un nuevo hipoglucemiante oral: glipentida (UR-661)